References
- Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007;65(12 Pt 2):S140-S146. https://doi.org/10.1301/nr.2007.dec.S140-S146
- Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002;16(2):217-226.
- Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109(21 Suppl 1):II2- II10. https://doi.org/10.1161/01.CIR.0000122867.89751.59
- Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med 2011;123(1):114-119. https://doi.org/10.3810/pgm.2011.01.2252
- NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2009;55(2):378-384. https://doi.org/10.1373/clinchem.2008.115899
- Makita S, Nakamura M, Satoh K, Tanaka F, Onoda T, Kawamura K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 2009;204(1):234-238. https://doi.org/10.1016/j.atherosclerosis.2008.07.040
- Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375(9709):132-140. https://doi.org/10.1016/S0140-6736(09)61717-7
- Ridker PM. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clin Chem 2008;54(2):234-237. https://doi.org/10.1373/clinchem.2007.099465
- Ahmadi-Abhari S, Luben RN, Wareham NJ, Khaw KT. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study. Eur J Epidemiol 2013;28(7):541-550. https://doi.org/10.1007/s10654-013-9819-6
- Goyal A, Terry MB, Jin Z, Siegel AB. C-reactive protein and colorectal cancer mortality in U.S. adults. Cancer Epidemiol Biomarkers Prev 2014;23(8):1609-1618. https://doi.org/10.1158/1055-9965.EPI-13-0577
- Sung KC, Ryu S, Chang Y, Byrne CD, Kim SH. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians. Eur Heart J 2014;35(27):1809-1816. https://doi.org/10.1093/eurheartj/ehu059
- Doran B, Zhu W, Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III. Am Heart J 2013;166(1):45-51. https://doi.org/10.1016/j.ahj.2013.03.017
- Kim KI, Oh SW, Ahn S, Heo NJ, Kim S, Chin HJ, et al. CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population. Am J Med 2012;125(8):787- 795.e4. https://doi.org/10.1016/j.amjmed.2012.02.013
- Ding D, Wang M, Su D, Hong C, Li X, Yang Y, et al. Body mass index, high-sensitivity C-reactive protein and mortality in Chinese with coronary artery disease. PLoS One 2015;10(8): e0135713. https://doi.org/10.1371/journal.pone.0135713
- Sung JW, Lee SH, Byrne CD, Chung PW, Won YS, Sung KC. High-sensitivity C-reactive protein is associated with the presence of coronary artery calcium in subjects with normal blood pressure but not in subjects with hypertension. Arch Med Res 2014;45(2):170-176. https://doi.org/10.1016/j.arcmed.2014.01.003
- Kengne AP, Batty GD, Hamer M, Stamatakis E, Czernichow S. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes Care 2012;35(2):396-403. https://doi.org/10.2337/dc11-1588
- Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem 2008;54(2):335-342. https://doi.org/10.1373/clinchem.2007.100271
- Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104(23):2855-2864. https://doi.org/10.1161/hc4701.099488
- Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart 2011;97(10):787-796. https://doi.org/10.1136/hrt.2010.218537
- Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008;54(6):1027-1037. https://doi.org/10.1373/clinchem.2007.098996
- Kim Y, Han BG; KoGES group. Cohort profile: the Korean genome and epidemiology study (KoGES) Consortium. Int J Epidemiol 2016. http://dx.doi.org/10.1093/ije/dyv316.
- Lee EH, Park SK, Ko KP, Cho IS, Chang SH, Shin HR, et al. Cigarette smoking and mortality in the Korean Multi-center Cancer Cohort (KMCC) study. J Prev Med Public Health 2010;43(2): 151-158 (Korean). https://doi.org/10.3961/jpmph.2010.43.2.151
- World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment [cited 2016 Sep 4]. Available from: http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf.
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.
- Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 1997;54(3):201-208. https://doi.org/10.1016/S0169-2607(97)00043-6
- Li R, Hertzmark E, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV9 macro; 2011 [cited 2016 Sep 4]. Available from: https://cdn1.sph.harvard.edu/wp-content/uploads/sites/271/2012/09/lgtphcurv9_7-3-2011.pdf.
- Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A; JACC Study Group. C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis 2009;207(1):291-297. https://doi.org/10.1016/j.atherosclerosis.2009.04.020
- Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94(4): 457-462. https://doi.org/10.1136/hrt.2007.118794
- Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107(3):499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45
- Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med 2005;352(15):1611-1613.
- Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis 2007;194(1):238-244. https://doi.org/10.1016/j.atherosclerosis.2006.07.032
- Zhao Y, Wang R, Ma X, Yan X, Zhang Z, He X, et al. Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese. Dis Markers 2010;28(6):333-342. https://doi.org/10.1155/2010/270126
- Organization for Economic Cooperation and Development. Health status [cited 2015 Nov 29]. Available from: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT.
- Kuoppamaki M, Salminen M, Vahlberg T, Irjala K, Kivela SL, Raiha I. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year follow-up study. Arch Gerontol Geriatr 2015;60(1):112-117. https://doi.org/10.1016/j.archger.2014.10.002
- Smith KB, Humphreys JS, Wilson MG. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health 2008;16(2):56-66. https://doi.org/10.1111/j.1440-1584.2008.00953.x
- Hage FG. C-reactive protein and hypertension. J Hum Hypertens 2014;28(7):410-415. https://doi.org/10.1038/jhh.2013.111
- Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009;373(9670):1175-1182. https://doi.org/10.1016/S0140-6736(09)60447-5
Cited by
- Sex differences in the association between self-rated health and high-sensitivity C-reactive protein levels in Koreans: a cross-sectional study using data from the Korea National Health and Nutrition vol.18, pp.1, 2016, https://doi.org/10.1186/s12955-020-01597-5